CrushSCI.com
Journal Selection & Manuscript Polishing Services
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES journal cover Medicine
Back to journal directory

Review Cycle Records

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Elsevier SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 32025 JCR Q1
101.7Average days
86Median days
44Fastest days
205Longest days
3912025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

73 days

The top-down Finite Time Pharmacokinetic (FTPK) models vis-a-vis the bottom-up PBPK models in early drug development

AuthorsPanos Macheras; Nikos Alimpertis; Athanasios A. Tsekouras

AffiliationsFaculty of Pharmacy, Laboratory of Biopharmaceutics Pharmacokinetics, National and Kapodistrian University of Athens, Athens, Greece; Finite Absorption Time (F.A.T.) Laboratories, National and Kapodistrian University of Athens, Athens, Greece; Department of Chemistry, Laboratory of Physical Chemistry, National and Kapodistrian University of Athens, Athens, Greece

Source PDF DOI Publisher page
144 days

Lipid nanoparticles for ursodeoxycholic acid delivery: A strategy for topical applications

AuthorsGiada Mondanelli; Vincenzo Falcone; Roberto Sauri; Bruno Cerra; Marco Gargaro; Maurizio Ricci; Aurélie Schoubben; Antimo Gioiello

AffiliationsDepartment of Pharmaceutical Sciences, University of Perugia, Perugia, Italy

Source PDF DOI Publisher page
47 days

M4 drug discovery: Human drug predictions from integrated preclinical insights exemplified with a GLP-1R agonist

AuthorsOscar Silfvergren; Sophie Rigal; Katharina Schimek; Christian Simonsson; Kajsa P Kanebratt; Felix Forschler; Burcak Yesildag; Uwe Marx; Liisa Vilén; Peter Gennemark; Gunnar Cedersund

AffiliationsDepartment of Biomedical Engineering, Linköping University, Linköping, Sweden; SUND sound medical decisions, Linköping, Sweden; TissUse GmbH, Berlin, Germany; Institute of Biotechnology, Technische Universität Berlin, Berlin, Germany; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; InSphero AG, Schlieren, Switzerland; Bioscience Technology Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; Center for Medical Image Science and Visualization (CMIV), Linköping University, Linköping, Sweden; School of Medical Sciences and Inflammatory Response and Infection Susceptibility Centre (iRiSC), Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Source PDF DOI Publisher page
75 days

Evaluation of Citicoline-loaded Lutrol 127/Carbopol/Hyaluronic acid-based gels for brain delivery by intranasal administration

AuthorsAnna Patrizia de Nichilo; Francesca Uberti; Adriana Trapani; Stefano Castellani; Giorgia Iaconisi; Giorgia Franzino; Cinzia Di Franco; Lorenzo Guerra; Rosanna Mallamaci; Rosa Angela Cardone; Carmelo Ventra; Domenico Larobina; Loredana Capobianco; Simone Mulè; Elvira De Giglio

AffiliationsDepartment of Pharmacy-Drug Sciences, University of Bari “Aldo Moro”, via E. Orabona, Bari, 4-70125, Italy; Department for Sustainable Development and Ecological Transition, University of Piemonte Orientale (UPO), Piazza Sant’Eusebio 5, Vercelli, 13100, Italy; Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe-J), University of Bari “Aldo Moro”, Bari, 70125, Italy; Department of Biological and Environmental Science and Technology, University of Salento, Via Lecce—Monteroni, Lecce, 73100, Italy; Consiglio Nazionale delle Ricerche Istituto per i Polimeri, Compositi e Biomateriali P. le Enrico Fermi, Naples, 1 80055, Italy; CNR-IFN Bari, Bari Via Amendola 173, 70126 Bari, Italy; Department of Biosciences, Biotechnologies and Environment, University of Bari “Aldo Moro”, Bari, 70125, Italy; Esseti Farmaceutici, Via Cavalli di Bronzo, 39-46, San Giorgio a Cremano, Naples, 80046, Italy .; Department of Chemistry, University of Bari “Aldo Moro”, Bari, 70125, Italy

Source PDF DOI Publisher page
97 days

FcBP-HFQ lipid-mediated trastuzumab modification of mRNA-loaded lipid nanoparticles enhances delivery to HER2-expressing cancer cells

AuthorsMakoto Matsumoto; Riku Takayama; Chiemi Matsuguchi; Haruki Shimada; Tatsunori Izumi; Naoya Kato; Ayaka Matsuo-Tani; Hikaru Nakamura; Takeshi Hiu; Takayuki Matsuo; Hidefumi Mukai; Shigeru Kawakami

AffiliationsGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan; Department of Neurosurgery, Graduate School of Biomedical Sciences, Nagasaki University, Japan

Source PDF DOI Publisher page
66 days

Differential myocardial responses to indobufen and aspirin across clinical and experimental models of myocardial infarction

AuthorsBryan Richard Sasmita; Bi Huang; Jiejie Yang; Suxin Luo; Yongzheng Guo

AffiliationsDepartment of Cardiology, Cardiovascular Research Center, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China; Key Laboratory of Circulatory System Stress and Disease of Chongqing Municipal Education Commission, Chongqing Medical University, Chongqing, 400016, China

Source PDF DOI Publisher page
120 days

Discovery of a Potent and Selective KRAS G12D Degrader based on PROTAC Degradation

AuthorsLili Jiang; Wenyan Yang; Yanqing Liu; Gangjian Li; Xiaomin Luo; Yubo Zhou; Jiangjiang Qin; Youlu Pan; Wenhai Huang

AffiliationsCenter of Safety Evaluation and Research, Key Laboratory of Drug Safety Evaluation and Research of Zhejiang Province, Hangzhou Medical College, Hangzhou, Zhejiang, 310053, China.; School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou 310000, China.; Zhuji People's Hospital of Zhejiang Province, Zhuji 311800, China.; Center for Innovative Drug Research, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.; Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, Guangdong 528400, China.; University of Chinese Academy of Sciences, Beijing, China.; School of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078(or Macau SAR), China.

Source PDF DOI Publisher page
44 days

Synthesis and biological evaluation of 68Ga-DOTA-PLE: a Plectin-1-targeted radiotracer for PET/MR imaging of pancreatic cancer

AuthorsZhi-Qiang Yu; Hongrui Shu; Yujie Wang; Shun Li; Zhen-Peng Yu; Weijia Zhao; Xue-Feng Zhao; Hong Zhu; Yi Du; Pai Peng; Hongwei Si; Peng-Fei Dai

AffiliationsDepartment of Nuclear Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China; School of Life Sciences, Anhui Medical University, Hefei, Anhui, 230032, China; Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China; Anhui province key laboratory of tumor immune microenvironment and immunotherapy, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230022, China

Source PDF DOI Publisher page
205 days

A new rational model for tablet strength-pressure relation

AuthorsJørn M. Sonnergaard

AffiliationsDepartment of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2500, Copenhagen Ø, Denmark

Source PDF DOI Publisher page
146 days

GW0742 prevents neointima formation by upregulating FABP3 expression

AuthorsXuesheng Wang; Jingjie Chen; Bo Huo; Xingliang Wu; Wenxin Lin; Ding-Sheng Jiang; Yu-Song Zhang; Xin Feng; Fu-Han Gong

AffiliationsDepartment of Cardiology, Tongren People's Hospital, Tongren, Guizhou, China; Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Key Laboratory of Organ Transplantation, Ministry of Education, Chinese Academy of Medical Sciences; NHC Key Laboratory of Organ Transplantation, Wuhan, Hubei, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.